|
HS Code |
322334 |
| Generic Name | Fludrocortisone Acetate |
| Brand Name | Florinef |
| Drug Class | Corticosteroid (mineralocorticoid) |
| Molecular Formula | C23H31FO6 |
| Molecular Weight | 444.49 g/mol |
| Route Of Administration | Oral |
| Primary Indication | Adrenocortical insufficiency (Addison's disease) |
| Mechanism Of Action | Increases sodium reabsorption and potassium excretion in the kidneys |
| Dosage Form | Tablet |
| Prescription Status | Prescription only |
| Appearance | White to off-white tablet |
| Storage Conditions | Store at 20° to 25°C (68° to 77°F) |
| Pregnancy Category | C |
| Common Side Effects | Hypertension, edema, hypokalemia, headache, muscle weakness |
As an accredited Fludrocortisone Acetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, opaque plastic bottle containing 100 tablets of Fludrocortisone Acetate 0.1 mg, secured with a tamper-evident child-resistant cap. |
| Shipping | Fludrocortisone Acetate should be shipped in tightly sealed, light-resistant containers, protected from moisture and extreme temperatures. It must be labeled according to regulatory guidelines, with proper documentation. Transportation should comply with hazardous material regulations, if applicable, and tracking is recommended to ensure timely delivery and integrity of the chemical during transit. |
| Storage | Fludrocortisone Acetate should be stored at controlled room temperature, ideally between 20°C to 25°C (68°F to 77°F). Keep the container tightly closed, protected from light and moisture. Store the chemical in a well-ventilated, secure area away from incompatible substances. Ensure that only authorized personnel have access, and follow all relevant regulations and safety protocols for storage. |
|
Purity 98%: Fludrocortisone Acetate with purity 98% is used in adrenal insufficiency treatment, where high purity ensures consistent mineralocorticoid efficacy. Stability temperature 25°C: Fludrocortisone Acetate stabilized at 25°C is used in pharmaceutical formulations, where optimal storage temperature preserves potency and shelf life. Fine particle size: Fludrocortisone Acetate with fine particle size is used in oral tablet manufacturing, where uniform particle distribution enhances absorption rates. Melting point 265°C: Fludrocortisone Acetate with a melting point of 265°C is used in sterile compound preparations, where thermal stability guarantees formulation integrity. Assay ≥97.5%: Fludrocortisone Acetate with assay ≥97.5% is used in hormonal replacement therapy, where precise dosing supports predictable pharmacological response. Moisture content <0.5%: Fludrocortisone Acetate with moisture content below 0.5% is used in long-term storage formulations, where reduced moisture prevents degradation and extends product lifespan. Pharmaceutical grade: Fludrocortisone Acetate of pharmaceutical grade is used in clinical endocrinology, where high-grade purity minimizes risk of adverse reactions. |
Competitive Fludrocortisone Acetate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Fludrocortisone Acetate stands as one of those complex molecules that demands every bit of care, patience, and control from a manufacturer. Our story with this corticosteroid started more than fifteen years ago, in a modest but ambitious facility where painstaking chemical synthesis meant early mornings, exact measurements, and frequent recalibration. Each batch seemed to have both its own distinct fingerprint and familiar echoes of the last, teaching us the subtle variables that push outcomes off target.
What we synthesize under the name Fludrocortisone Acetate is the pure, microcrystalline form, produced by a carefully controlled esterification process using high-purity raw materials and rigorously validated methods. The effort isn't just about following a formula—the real challenge comes from the sterile isolation, the many filtration cycles, and the threat of minute contaminants which might pass unnoticed if not for continual, stubborn diligence. In-process checks set our discipline apart. The white crystalline powder we finish with passes visual, analytical, and biological scrutiny before it moves one step forward.
Fludrocortisone Acetate we supply falls under the model CAS number 514-36-3, with verified chemical formula C23H31FO6. The melting point, which regular customers often ask about, averages 260°C with no visible decomposition at standard bench protocol. Water content holds steady below 1.0%, particle size distribution remains tight between 30-80 microns—parameters we've set to match robust dissolution and consistent blending in downstream pharmaceutical applications.
Our continuous thermal and chemical monitoring reduces batch-to-batch surprises. Every kilogram leaves the reactor only after full trace chain documentation, reviewed by at least two independent analysts. The direct synthesis route we follow eliminates the use of chlorinated solvents, reducing both risks and waste by-products for clients whose compliance teams monitor environmental impact.
What this structure gives formulators is reliability and peace of mind. Knowing the physical and chemical stabilities beforehand allows our partners to tune their own manufacturing schedules and regulatory submissions with fewer last-minute surprises.
Inside clinics and pharmacies, fludrocortisone acetate fulfills a very narrow but important therapeutic need. Many generic corticosteroids flood the market, but few provide the targeted mineralocorticoid support required in conditions like Addison's disease or salt-losing adrenogenital syndrome. Every gram we deliver becomes a critical ingredient for life-saving tablets or injectable solutions that restore electrolyte balance and keep hospital readmissions at bay.
We have watched how even minor inconsistencies in active ingredient quality can ripple downstream—causing batch failures, gifting regulatory headaches, or even affecting patient adherence when tablets crumble or dissolve incorrectly. For manufacturing partners, a slightly shifted moisture profile might threaten the taste, shelf-life, or dissolution time. Our teams engage directly with pharmaceutical formulators to share knowledge and co-design packaging or release protocols, narrowing the margin for error to almost zero.
By closely controlling particle size, reducing detectable impurities below the tightest pharmacopeial standards, and shipping under validated transport conditions, we create a buffer against last-mile issues. Our packaging—double-layered, light-protective aluminum with inner sterile liners—addresses firsthand complaints regarding earlier, more fragile carriers that allowed temperature or humidity intrusion.
A glance at the corticosteroid market often leaves buyers and formulators asking, “How does fludrocortisone acetate stand out?” From our manufacturing floor, the difference emerges during synthesis and in its final biological action. Most steroidal actives—hydrocortisone, prednisone, dexamethasone—show strong glucocorticoid effects but lack the specific mineralocorticoid push needed for electrolyte management. Fludrocortisone acetate, with its unique fluorine substitution on the steroid backbone, triggers the retention of sodium and excretion of potassium, directly modulating blood pressure and salt balance.
Unlike multi-purpose corticosteroids, this product commands smaller production runs yet stricter controls. With a lower threshold for impurity limits—especially for fluorine-containing residuals, heavy metals, and solvent traces—our teams spend more time fine-tuning purification. The margin for error is slim; patient groups using fludrocortisone acetate are sometimes children or elderly individuals whose systems tolerate inconsistency poorly.
A further contrast becomes obvious during the final steps, when fludrocortisone acetate demands sterilization and anti-caking precautions beyond what general glucocorticoids require. Temperature-sensitive packaging, quick logistics, and clear chain-of-custody all play a role. Only the most reliable, transparent manufacturing chains succeed in consistently delivering safe, uncompromised product to market.
Managing a pharmaceutical ingredient like fludrocortisone acetate calls for rigor that stretches beyond the paper trail. Our on-site microbiological and chemical labs operate to international cGMP standards, with each analyst accountable under direct supervision. Sample vials from every lot stay in climatized storage for five years, ready for re-testing on client request or audit. Regular third-party inspections provide an extra layer of confidence to regulatory agencies across multiple continents.
Customer requirements sometimes leave textbooks behind. Over the years, we’ve received requests to tune micronization protocols, adjust the final de-aeration parameters, or screen for new classes of extraneous peaks in chromatograms. Instead of one-size-fits-all answers, we dedicate scientific liaisons—engineers with hands-on plant knowledge—to support complicated tech-transfer projects or validation campaigns.
Feedback plays a vital role. Several years ago, a hospital partner flagged unexpected discoloration in a finished product. Post-shipment root-cause analysis revealed a subtle interaction between our acetate salt and a previously inert polymer used in certain tablet binders. We adapted our own manufacturing controls, sharing new data with the downstream team. Transparent adjustments like these reinforce our commitment to two-way problem-solving and elevate long-term trust.
Shipping a controlled corticosteroid like fludrocortisone acetate extends beyond the batch certificate. Complying with regional guidelines, ranging from USP and EP monographs to ICH Q3D elemental impurity standards, anchors our operations. We keep complete data records and fulfill custom document requests, streamlining client regulatory submissions and facilitating international audits.
Protecting the supply chain against counterfeiting and fraud matters just as much. Each drum departs our plant tagged with tamper-evident seals, QR-enabled documentation, and unique lot identities traceable to source material intake. Regular in-house and cross-company security reviews promote integrity and remove weak links from procurement to final delivery.
Environmental commitments augment our core mission. Over the past decade, our plant teams have replaced older solvent systems and installed continuous emission monitoring to reduce air and water discharge. Engaging directly with local communities, we’ve built recycling facilities and emergency networks. Our ambition: manufacture without burdening the environment or neighboring businesses, offering clean chemical stewardship along with every drum.
Any operation working with corticosteroids lives with constant scrutiny—review from regulatory inspectors, queries from R&D partners, surprise checks by insurance stakeholders. Adapting to changing guidelines, tougher residue limits, or new analytical requests keeps our teams sharp and engaged, especially as therapeutic use expands and demands on purity tighten.
Price pressures loom in every specialty chemical line. Cheap imports and parallel manufacturers sometimes flood markets with lower-priced APIs that meet paperwork but struggle in real-world blending or stability. This is where traceability, direct plant-to-pharma relationships, and transparency matter. We’ve weathered commodity cycles and pricing wars by showing that cutting process corners today leads to risk, waste, and reputational harm tomorrow.
Open-door scientific partnerships offer our clients more than shipments. Teams regularly visit customer sites for process audits, technical troubleshooting, and collaborative research sessions. By sharing elemental profiling data, reaction time logs, or lessons learned from prior campaigns, we strengthen every part of the pharmaceutical value chain.
Digital tools accelerate these connections. From real-time shipment tracking to secure document sharing, we reduce the barriers to rapid decision-making. Recently, after natural disasters closed air routes, we utilized multi-country ground transport networks to keep time-sensitive batches moving, minimizing loss and delay.
Over years of direct manufacturing, we’ve watched minor distractions turn into major breakthroughs. Early on, one persistent bottleneck involved purifying residual solvents without impacting yield. Trials with various resins and adsorbents led to incremental improvements that, when aggregated, saved thousands of hours and drastically lowered impurity counts.
Each process intervention starts with direct operator feedback—workers standing beside the reactor, analysts monitoring HPLC output—feeding practical insights back to the design desk. This iterative improvement, grounded in daily experience and not just management edicts, powers our steady gains in safety, quality, and plant reliability.
We measure our success as much by reduced deviation rates and customer satisfaction as by batch yields or sales volumes. Cross-training, routine scenario drills, and transparent incentive systems keep skills sharp and motivation high, ensuring the next improvement is always within reach.
Our ethical vision for fludrocortisone acetate, shaped by direct experience and collective pride, guides every investment in equipment upgrades, staff training, and client cooperation. Failures or mistakes get tackled head-on, with solutions broadcast through open forums to spark better practices across our entire network.
Supplying an advanced molecule like fludrocortisone acetate comes with a burden of care. On-the-ground decisions each day affect not just the product’s quality but its long journey into finished dose forms, patient hands, and ultimately, the broader goals of public health.
Our workers know the stakes. Whether they’re preparing raw material, testing finished powder, or signing outbound manifests, the knowledge that the compound they produce underpins therapy for vulnerable patients keeps standards high. No cut corners, no unexplained variance, and no silence when a problem creeps into the mix.
This attitude reverberates in every improvement we adopt, every question we answer for partners, and every time we reject an easy shortcut in favor of doing the job with scrutiny and pride. We see our task not just as making a substance, but as shepherding possibility—giving the world a pharmaceutical tool that performs at its best, when and where it matters most.
With every request, every feedback session, and every new challenge, we continue to invest in both our technical expertise and collaborative spirit, confident that our record with fludrocortisone acetate reflects more than just chemistry: it shows respect for every life the product may touch.